In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study.

BACKGROUND Cryoablation has been used successfully for the local treatment of several cancers. Besides local destruction, a systemic antitumor response has been postulated after cryoablation of tumor tissue. In this study we evaluate the possible systemic antitumor response induced by cryodestruction of tumor tissue in two mouse tumor models. METHODS Mice received two subcutaneously placed tumor implants (thigh and flank) of the nonimmunogenic mouse colon tumor cell line, colon 26-B. After 7 days, the thigh implant was treated by cryoablation or excision and the effect on secondary tumor growth was determined by volume measurement of the nontreated flank tumor. Cytokine (IL-1alpha and TNF-alpha) levels in plasma were measured after treatment. Similar experiments were performed in nude mice using a human melanoma cell line (MV3). Moreover, in this model the effect of cryoablation on development of spontaneous lung metastases was evaluated. RESULTS In the colon 26-B tumor model treatment of primary tumor implants by cryoablation resulted in a significant inhibition of secondary tumor growth compared to animals treated by surgical excision (P < 0.01). Six hours after treatment, plasma levels of IL-1alpha and TNF-alpha were higher after cryoablation than after excision (P < 0.01). Also in the nude mice model cryoablation resulted in inhibition of secondary tumor growth, though not significant. Mice treated by cryoablation showed significantly less lung metastases compared to those treated by excision (P = 0.03). CONCLUSIONS Cryoablation of tumor tissue can result in inhibition of secondary and metastatic tumor growth. A cytokine response induced by cryoablation of tumor tissue may attribute to this feature.

[1]  Immunological analysis of enhanced spontaneous metastasis in WKA rats following cryosurgery. , 1998, Anticancer research.

[2]  C. Blackwood,et al.  Response of experimental tumor systems to cryosurgery. , 1972, Cryobiology.

[3]  F. T. Moore,et al.  Cryotherapy for malignant tumors. Immunologic response. , 1968, Archives of surgery.

[4]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Kuhn,et al.  Cryosurgical ablation of hepatic tumors. , 1997, American journal of surgery.

[6]  T. Ravikumar,et al.  Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. , 1991, Cancer research.

[7]  D. Ruiter,et al.  Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice , 2007, International journal of cancer.

[8]  W. A. Soanes,et al.  Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. , 1970, The Journal of urology.

[9]  R. E. Ritts,et al.  Immunotherapeutic effect of tumor necrosis after cryosurgery, electrocoagulation, and ligation , 1979, Journal of surgical oncology.

[10]  R. Rees,et al.  Comparison of excision versus cryosurgery of an HSV-2-induced fibrosarcoma , 1988, Cancer Immunology, Immunotherapy.

[11]  A A Gage,et al.  History of cryosurgery. , 1998, Seminars in surgical oncology.

[12]  In vitro demonstration of cryosurgical augmentation of tumor immunity. , 1975, Surgery.

[13]  T. Ravikumar,et al.  A 5-year study of cryosurgery in the treatment of liver tumors. , 1991, Archives of surgery.

[14]  S. Shulman,et al.  Studies in cryo-immunology. II. Tissue and species specificity of the autoantibody response and comparison with iso-immunization. , 1968, Immunology.

[15]  N N Korpan,et al.  Hepatic cryosurgery for liver metastases. Long-term follow-up. , 1997, Annals of surgery.

[16]  G. Peters,et al.  Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. , 1987, In vivo.

[17]  W. Fiers,et al.  The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity , 1988, The Journal of experimental medicine.

[18]  W. A. Soanes,et al.  Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate. , 1971, Cryobiology.

[19]  A. Cuschieri,et al.  Effective Hepatic Cryoablation: Does It Enhance Tumor Dissemination? , 1999, World Journal of Surgery.

[20]  W. Chapman,et al.  Acute lung injury after hepatic cryoablation: Correlation with NF-κB activation and cytokine production , 1999 .

[21]  M. Micallef,et al.  Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery. , 1998, Anticancer research.

[22]  S. Saji,et al.  Immunological response of regional lymph nodes after tumor cryosurgery: experimental study in rats. , 1986, Cryobiology.

[23]  A. Li,et al.  A comparison of cryodestruction with excision or infarction of an implanted tumor in rat liver. , 1984, Cryobiology.

[24]  H. Bismuth,et al.  Place of cryosurgery in the treatment of malignant liver tumors. , 1997, Annals of surgery.

[25]  R. Beazley,et al.  Lymphocyte mediated cytotoxicity after cryosurgery of a murine sarcoma. , 1974, The Journal of surgical research.

[26]  J. Willson,et al.  Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines. , 1987, Cancer research.

[27]  R. Goris,et al.  Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. , 1996, Critical care medicine.

[28]  N. Bloksma,et al.  Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity , 1989, The Journal of pathology.